The avoidable delay in the care of STEMI patients is still a priority issue
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference10 articles.
1. Changes in patient characteristics, mangement, and 6-month outcomes over a period of 20 years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015;Puymirat;Circulation,2017
2. Contemporary trends and age-specific sex differences in management and outcome for patients with ST-segment elevation myocardial infarction;De Luca;J. Am. Heart Assoc.,2016
3. Time from symptom onset to treatment and outcomes after thrombolytic therapy;Kristin Newby;J. Am. Coll. Cardiol.,1996
4. Relationship of symptoms-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction;Cannon;JAMA,2000
5. Relation of time to treatment and mortality in patients with acute myocardial infarction undergoing primary coronary angioplasty;Antoniucci;Am. J. Cardiol.,2002
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prehospital Factors Contributing to Delays in the Timely Management of ST-Elevation Myocardial Infarction;Jundishapur Journal of Health Sciences;2024-08-19
2. Advancements in reperfusion rates and quality of care for ST-segment elevation myocardial infarction: a ten-year evaluation of Salvador's STEMI network;Frontiers in Cardiovascular Medicine;2024-07-22
3. Addressing the Primary Causes of Door-in to Door-out Time Delay in ST-elevation Myocardial Infarction: Can They be Minimised;Eurasian Journal of Emergency Medicine;2024-03-01
4. Impact of historical Partitions of Poland on reperfusion delay in patients with ST-elevation myocardial infarction referred to primary percutaneous coronary intervention (from the ORPKI Registry);Polish Archives of Internal Medicine;2024
5. Cyclocreatine Phosphate: A Novel Bioenergetic/Anti-Inflammatory Drug That Resuscitates Poorly Functioning Hearts and Protects against Development of Heart Failure;Pharmaceuticals;2023-03-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3